159 related articles for article (PubMed ID: 22343543)
1. Admission glucose does not improve GRACE score at 6 months and 5 years after myocardial infarction.
de Mulder M; van der Ploeg T; de Waard GA; Boersma E; Umans VA
Cardiology; 2011; 120(4):227-34. PubMed ID: 22343543
[TBL] [Abstract][Full Text] [Related]
2. Mitral regurgitation during a myocardial infarction--new predictors and prognostic significance at two years of follow-up.
Barra S; Providência R; Paiva L; Gomes PL; Seca L; Silva J; Nascimento J; Leitão-Marques A
Acute Card Care; 2012 Mar; 14(1):27-33. PubMed ID: 22296621
[TBL] [Abstract][Full Text] [Related]
3. Anaemia to predict outcome in patients with acute coronary syndromes.
Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score.
Timóteo AT; Papoila AL; Rio P; Miranda F; Ferreira ML; Ferreira RC
Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):257-63. PubMed ID: 24687188
[TBL] [Abstract][Full Text] [Related]
5. Fasting glucose in acute myocardial infarction: incremental value for long-term mortality and relationship with left ventricular systolic function.
Aronson D; Hammerman H; Kapeliovich MR; Suleiman A; Agmon Y; Beyar R; Markiewicz W; Suleiman M
Diabetes Care; 2007 Apr; 30(4):960-6. PubMed ID: 17392556
[TBL] [Abstract][Full Text] [Related]
6. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome.
Tang EW; Wong CK; Herbison P
Am Heart J; 2007 Jan; 153(1):29-35. PubMed ID: 17174633
[TBL] [Abstract][Full Text] [Related]
7. ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratification.
Yan AT; Yan RT; Tan M; Chow CM; Fitchett DH; Georgescu AA; Hassan Q; Luchansky J; Langer A; Goodman SG;
Am Heart J; 2006 Aug; 152(2):270-6. PubMed ID: 16875907
[TBL] [Abstract][Full Text] [Related]
8. Hospital discharge risk score system for the assessment of clinical outcomes in patients with acute myocardial infarction (Korea Acute Myocardial Infarction Registry [KAMIR] score).
Kim HK; Jeong MH; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
Am J Cardiol; 2011 Apr; 107(7):965-971.e1. PubMed ID: 21256468
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.
Dhillon OS; Khan SQ; Narayan HK; Ng KH; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
J Am Coll Cardiol; 2010 Jul; 56(2):125-33. PubMed ID: 20620726
[TBL] [Abstract][Full Text] [Related]
10. [Prediction of cerebrovascular event risk following myocardial infarction].
Barra S; Providência R; Lourenço Gomes P; Silva J; Seca L; Nascimento J; Leitão-Marques AM
Rev Port Cardiol; 2011 Jul; 30(7-8):655-63. PubMed ID: 22005309
[TBL] [Abstract][Full Text] [Related]
11. C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study.
Narayan H; Dhillon OS; Quinn PA; Struck J; Squire IB; Davies JE; Ng LL
Clin Sci (Lond); 2011 Jul; 121(2):79-89. PubMed ID: 21309746
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of point of care B-type natriuretic peptide testing and GRACE score in patients with acute coronary syndrome].
Sun YH; Wang GL; Fu YY; Xue C; Hu DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):716-20. PubMed ID: 20021924
[TBL] [Abstract][Full Text] [Related]
13. Does acute hyperglycemia add prognostic value to the GRACE score in individuals with non-ST elevation acute coronary syndromes?
Correia LC; Rocha MS; Bittencourt AP; Freitas R; Souza AC; Almeida MC; Péricles Esteves J
Clin Chim Acta; 2009 Dec; 410(1-2):74-8. PubMed ID: 19804768
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the performance of the Global Registry of Acute Coronary Events risk-adjustment index across socioeconomic strata among patients discharged from the hospital after acute myocardial infarction.
Alter DA; Venkatesh V; Chong A;
Am Heart J; 2006 Feb; 151(2):323-31. PubMed ID: 16442894
[TBL] [Abstract][Full Text] [Related]
15. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention.
Straumann E; Kurz DJ; Muntwyler J; Stettler I; Furrer M; Naegeli B; Frielingsdorf J; Schuiki E; Mury R; Bertel O; Spinas GA
Am Heart J; 2005 Nov; 150(5):1000-6. PubMed ID: 16290985
[TBL] [Abstract][Full Text] [Related]
16. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS.
de Araújo Gonçalves P; Ferreira J; Aguiar C; Seabra-Gomes R
Eur Heart J; 2005 May; 26(9):865-72. PubMed ID: 15764619
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Hoebers LP; Damman P; Claessen BE; Vis MM; Baan J; van Straalen JP; Fischer J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
Am J Cardiol; 2012 Jan; 109(1):53-9. PubMed ID: 21944676
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction.
Kelly D; Squire IB; Khan SQ; Dhillon O; Narayan H; Ng KH; Quinn P; Davies JE; Ng LL
Am J Cardiol; 2010 Aug; 106(4):477-82. PubMed ID: 20691304
[TBL] [Abstract][Full Text] [Related]
19. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
[TBL] [Abstract][Full Text] [Related]
20. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus.
Stranders I; Diamant M; van Gelder RE; Spruijt HJ; Twisk JW; Heine RJ; Visser FC
Arch Intern Med; 2004 May; 164(9):982-8. PubMed ID: 15136307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
